Lantern
PrivateLast Round
Growth Equity
Mar 19, 2026
Est. Valuation
$1B
Total Funding Raised
$31M
Company Overview
Lantern, formerly known as Employer Direct Healthcare, is a specialty care platform that provides services to self-funded employers. The company connects members with its curated 'Network of Excellence,' which comprises top-performing specialists for surgery, cancer care, and infusion therapies. Lantern aims to deliver high-quality, accessible, and affordable specialty care, thereby reducing healthcare costs for both employers and their employees. The platform pairs members with a dedicated care team, including Care Advocates and nurses, to guide them through their healthcare journey. Founded in 2011, the company rebranded from Employer Direct Healthcare to Lantern in September 2024 to better reflect its mission of guiding members to the best possible care.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, Vertical SaaS, Patient Engagement, Revenue Cycle, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Usage-Based SaaS, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lantern Comps
Public and private peers based on sector, stage, and business model.
Lantern Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Mar 19, 2026 | ||||
| Secondary | Dec 19, 2023 | ||||
| Growth Equity | Jul 28, 2021 | ||||
| Growth Equity | Oct 27, 2020 | ||||
| Series C | Jan 12, 2016 | ||||
Series A | May 1, 2011 |
Key People
Founding team and executive leadership
Lantern Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Secondary, Growth Equity |
| Morgan Health | Growth Equity |
| Dundon Capital Partners | Growth Equity, Series C |
| Serent Capital | Secondary, Growth Equity |
| TEXO Ventures | Series A, Series C |
| Echo Health Ventures | Growth Equity |
| Insight Partners | Secondary |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
Named to Fast Company's Most Innovative Companies list.
- Mar 19, 2026
$30M round completed.
Lantern Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lantern's valuation, stock price, and market status.
